Skip to main content

Table 1 Summary of AGREE II structure and detailed list of items within each domain (from reference 15)

From: A critical appraisal of the quality of adult musculoskeletal ultrasound guidelines using the AGREE II tool: an EuroAIM initiative

Domain 1. Scope and purpose
Item 1 The overall objective(s) of the guideline is (are) specifically described
Item 2 The health question(s) covered by the guideline is (are) specifically described
Item 3 The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described.
Domain 2: Stakeholder involvement
Item 4 The guideline development group includes individuals from all the relevant professional groups.
Item 5 The views and preferences of the target population (patients, public, etc.) have been sought.
Item 6 The target users of the guideline are clearly defined.
Domain 3: Rigor of development
Item 7 Systematic methods were used to search for evidence.
Item 8 The criteria for selecting the evidence are clearly described.
Item 9 The strengths and limitations of the body of evidence are clearly described.
Item 10 The methods for formulating the recommendations are clearly described.
Item 11 The health benefits, side effects, and risks have been considered in formulating the recommendations.
Item 12 There is an explicit link between the recommendations and the supporting evidence.
Item 13 The guideline has been externally reviewed by experts prior to its publication.
Item 14 A procedure for updating the guideline is provided.
Domain 4: Clarity of presentation
Item 15 The recommendations are specific and unambiguous.
Item 16 The different options for management of the condition or health issue are clearly presented.
Item 17 Key recommendations are easily identifiable.
Domain 5: Applicability
Item 18 The guideline describes facilitators and barriers to its application.
Item 19 The guideline provides advice and/or tools on how the recommendations can be put into practice.
Item 20 The potential resource implications of applying the recommendations have been considered.
Item 21 The guideline presents monitoring and/or auditing criteria.
Domain 6: Editorial independence
Item 22 The views of the funding body have not influenced the content of the guideline.
Item 23 Competing interests of guideline development group members have been recorded and addressed.